B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. · Biotechnology.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income · posted Apr 9, 2026

Lobbying activity 1

Pharmacy

Issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem